Related Experiment Videos
Comparative CD43 behavior on monocytes and lymphocytes in kidney transplants
Nephron
|November 30, 2000
Summary
CD43 dys-sialylation, a modification of sialic acid epitopes, is observed in kidney transplant recipients (KTR) monocytes. This alteration, potentially linked to cyclosporin, may affect monocyte function and adhesion.
Area of Science:
- Immunology
- Cell Biology
- Transplantation Science
Background:
- CD43 exhibits sialylation modifications in cytokine-stimulated human monocytic cells.
- Monocytes play critical roles in immune responses and post-transplant complications.
Purpose of the Study:
- To investigate CD43 expression and sialylation status on monocytes from kidney transplant recipients (KTR).
- To explore the potential role of cyclosporin (CsA) in CD43 dys-sialylation in KTR.
Main Methods:
- Flow cytometry using monoclonal antibodies targeting sialic acid-dependent (L60) and -independent (L10) CD43 epitopes.
- Analysis of CD43 expression on monocytes and lymphocytes from KTR and healthy controls.
- In vitro experiments using THP-1 (monocytic) and Jurkat (lymphoid) cell lines treated with CsA.
Main Results:
- KTR monocytes showed altered CD43 expression profiles, with decreased L60 staining in 54% and a double population in 20% of patients.
- Decreased CD43 sialylation (dys-sialylation) was more prevalent in KTR within 3 months post-transplantation.
- L10 epitope expression remained unaltered, confirming dys-sialylation, and CsA treatment reduced CD43 expression in monocytic cells but not lymphoid cells.
Conclusions:
- Kidney transplant recipients exhibit CD43 dys-sialylation on monocytes, particularly in the early post-transplant period.
- Cyclosporin may contribute to this dys-sialylation, potentially impacting monocyte adhesion and function in KTR.